TITLE 856 INDIANA BOARD OF PHARMACY
LSA Document #14-177(E)
Temporarily amends 856 IAC 2-2-2
to add synthetic drug compounds to Schedule I. Statutory authority: IC 25-26-13-4.1
. Effective 30 days after filing with the Publisher.
(b) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following synthetic substances, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subsection only, "isomer" includes the optical, position, and geometric isomers):
(1) APDB; other names include –EMA, 4-Desoxy-MDA, and (2-Aminopropyl)-2,3-dihydrobenzofuran.
(2) THJ-2201; other names include - AM2201 indazole analog, Fluoropentyl-JWH-018 indazole, and 5-Fluoro-THJ-018.
(3) AM2201 benzimidazole analog; other names include – FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone.
(4) MN-25; other names include - 7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide and UR-12.
Filed with Publisher: May 13, 2014, 2:27 p.m.
Posted: 05/21/2014 by Legislative Services Agency
Composed: Jul 06,2015 8:50:00PM EDT
version of this document.